Pro

Adi Lahat, MD, Doctor at the Institute of Gastroenterology and Liver Diseases, Chaim Sheba Medical Center (Israel), et al., stated the following in their Jan. 2012 Digestion article, "Impact of Cannabis Treatment on the Quality of Life, Weight, and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study":

“In the present preliminary prospective study, we have found that treatment with inhaled cannabis improves quality of life in patients with long-standing CD [Crohn’s disease] and UC [ulcerative colitis]. Treatment was also shown to cause a statistically significant rise in patients’ weight after 3 months of treatment, and improvement in clinical disease activity index in patients with CD…

Moreover, the data demonstrated a statistically significant improvement in almost all aspects of patients’ daily life. After 3 months’ treatment with inhaled cannabis, patients stated an improvement in their health status, their ability to perform daily activities and their ability to maintain social life. Patients reported a statistically significant physical pain reduction during treatment, as well as improvement in mental distress…

None of our patients complained of any side effect that disturbed their working ability. In fact, as was shown in the results, there was a statistically significant improvement in patients’ ability to work after treatment.”

Jan. 2012